Abstract:RNAs play critical roles in diverse catalytic and regulatory biological processes and are emerging as important disease biomarkers and therapeutic targets. Thus, developing chemical compounds for targeting any desired RNA structures has great potential in biomedical applications. The viral and cellular RNA sequence and structure databases lay the groundwork for developing RNA-binding chemical ligands through the recognition of both RNA sequence and RNA structure. Influenza A virion consists of eight segments of negative-strand viral RNA (vRNA), all of which contain a highly conserved panhandle duplex structure formed between the first 13 nucleotides at the 5' end and the last 12 nucleotides at the 3' end. Here, we report our binding and cell culture anti-influenza assays of a short 10-mer chemically modified double-stranded RNA (dsRNA)-binding peptide nucleic acid (PNA) designed to bind to the panhandle duplex structure through novel major-groove PNA-RNA(2) triplex formation. We demonstrated that incorporation of chemically modified PNA residues thiopseudoisocytosine (L) and guanidine-modified 5-methyl cytosine (Q) previously developed by us facilitates the sequence-specific recognition of Watson-Crick G-C and C-G pairs, respectively, at physiologically relevant conditions. Significantly, the chemically modified dsRNA-binding PNA (dbPNA) shows selective binding to the dsRNA region in panhandle structure over a single-stranded RNA (ssRNA) and a dsDNA containing the same sequence. The panhandle structure is not accessible to traditional antisense DNA or RNA with a similar length. Conjugation of the dbPNA with an aminosugar neamine enhances the cellular uptake. We observed that 2-5 mu M dbPNA-neamine conjugate results in a significant reduction of viral replication. In addition, the 10-mer dbPNA inhibits innate immune receptor RIG-I binding to panhandle structure and thus RIG-I ATPase activity. These findings would provide the foundation for developing novel dbPNAs for the detection of influenza viral RNAs and therapeutics with optimal antiviral and immunomodulatory activities.

RNA Secondary Structure as a First Step for Rational Design of the Oligonucleotides towards Inhibition of Influenza A Virus Replication

Exploring the molecular mechanism of action between drug and RNA polymerase based on partially-resolved spatial structures.

Viral RNA Polymerase: A Promising Antiviral Target for Influenza A Virus

Polycation-mediated delivery of siRNAs for prophylaxis and treatment of influenza virus infection.

RNA Interference of Influenza Virus Production by Directly Targeting Mrna for Degradation and Indirectly Inhibiting All Viral RNA Transcription

The structure of the influenza A virus genome

Design, synthesis, and biological activity of a novel series of 2-ureidonicotinamide derivatives against influenza A virus

Mapping of the Influenza A Virus Genome RNA Structure and Interactions Reveals Essential Elements of Viral Replication

Optimised design of siRNA based on multi-featured comparison and analysis of H1N1 virus.

Synthesis, Optimization, and Structure-Activity Relationships of Imidazo[1,2- a]pyrimidines as Inhibitors of Group 2 Influenza A Viruses

Recent advances in the structure-based design of neuraminidase inhibitors as antiinfluenza agents.

RNA Polymerase As a Promising Target for Anti-Influenza Virus Agents

795. RNA Interference of Influenza Virus Infection

A Short Chemically-Modified dsRNA-Binding PNA (dbPNA) Inhibits Influenza Viral Replication by Targeting Viral RNA Panhandle Structure.

Inhibition of Influenza Virus Production in Virus-Infected Mice by RNA Interference.

Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis

Structural insight into RNA synthesis by influenza D polymerase

Potential Role of Endonuclease Inhibition and Other Targets in the Treatment of Influenza

Recent Advances in the Molecular Design and Applications of Viral RNA-targeting Antiviral Modalities

Structural Studies of Inhibitors with Clinically Relevant Influenza Endonuclease Variants

Use of Sirnas to Prevent and Treat Influenza Virus Infection